Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2+/Akita:apoE−/− mice
Authors:
- 1 December 2012
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 225 (2) , 341-347
Abstract
No abstract availableKeywords
Funding Information
- Pennsylvania State University College of Medicine
- WW Smith Charitable Trust
- National Heart, Lung, and Blood Institute/National Institutes of Health (R01-HL-097090)
- University of Cincinnati Mouse Metabolic Phenotyping Center (U24-DK-059630)
This publication has 30 references indexed in Scilit:
- Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolismJournal of Clinical Investigation, 2012
- Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese miceJournal of Clinical Investigation, 2012
- Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: The Heart and Soul StudyAtherosclerosis, 2011
- Spontaneously diabetic Ins2+/Akita:apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosisAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Insulin-dependent Diabetes Mellitus in Mice Does Not Alter Liver Heparan SulfateJournal of Biological Chemistry, 2010
- Leptin therapy in insulin-deficient type I diabetesProceedings of the National Academy of Sciences of the United States of America, 2010
- Liver-Specific Loss of Lipolysis-Stimulated Lipoprotein Receptor Triggers Systemic Hyperlipidemia in MiceDiabetes, 2009
- Inactivation of Hepatic Foxo1 by Insulin Signaling Is Required for Adaptive Nutrient Homeostasis and Endocrine Growth RegulationCell Metabolism, 2008
- Leptin and Cardiovascular DiseaseCirculation, 2008
- Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizingJournal of Clinical Investigation, 2007